PATENT CLAIM ANALYSIS

Application Number: 15955968
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-09
Patent Classification: ["514", "282000"]

Abstract:
The invention describes pharmaceutical compounds and compositions comprised of a ligand attached to the opioid oxymorphone, in a manner that substantially decreases or deters the potential for opioid abuse, addiction, illicit and illegal use, and overdose. When delivered at the proper dosage, the pharmaceutical composition provides therapeutic activity similar to that of the parent active agent.

Claim (Index 13):
The oxymorphone prodrug according to  claim 9  wherein the alpha-hydroxy carboxylic acid is selected from the group consisting of lactic acid, tartaric acid, malic acid, citric acid, mandelic acid, pantoic acid, pantothenic acid and poly-hydroxy carboxylic acids derived from sugars and carbohydrates.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 91.0
- Lexical Diversity: 1.36957
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14956143', '15472758', '14953392', '12302764', '15795126']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.819442150995924
- 35 USC 102 Novelty (BERT): 0.5478116545662955
- Combined Prediction Score: 0.7922791013529612
- Mean Citation Score: 331.6975280000001
- Max Citation Score: 411.44037
- Similarity Product: 281.6176572800464

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test